Conduction Disorders and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Implantation

  • Jorn BrouwerEmail author
  • Vincent J. Nijenhuis
  • Uday Sonker
  • Jurrien M. ten Berg


Transcatheter aortic valve implantation (TAVI) has been adopted rapidly as a minimal invasive therapeutic alternative to surgical aortic valve replacement for patients with severe aortic stenosis, who are considered inoperable or at high surgical risk. Several TAVI-related complications, e.g. paravalvular leakage, have decreased over time, which is not the case for the incidence of conduction disorders. On the contrary, the development of conduction disorders still is the most prevalent complication and probably is unavoidable as it is due to close anatomical relation between cardiac conduction system and aortic valvular complex. The most prevalent TAVI-induced conduction disorders are new-onset left bundle branch block and high-degree atrioventricular block requiring permanent cardiac pacing. This chapter provides a brief overview of different aspects of conduction disorders following TAVI such as incidence, risk factors, outcome and prognosis, as well as its management.


Transcatheter aortic valve implantation Conduction disorders Left bundle branch block Permanent pacemaker implantation High-degree atrioventricular block 


Conflict of Interest



  1. 1.
    Martinez-Selles M, Bramlage P, Thoenes M, Schymik G. Clinical significance of conduction disturbances after aortic valve intervention: current evidence. Clin Res Cardiol. 2015;104(1):1–12.PubMedCrossRefGoogle Scholar
  2. 2.
    Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–607.CrossRefGoogle Scholar
  3. 3.
    Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–98.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–20.CrossRefGoogle Scholar
  5. 5.
    Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370(19):1790–8.CrossRefGoogle Scholar
  6. 6.
    Young Lee M, Chilakamarri Yeshwant S, Chava S, Lawrence Lustgarten D. Mechanisms of heart block after transcatheter aortic valve replacement: cardiac anatomy, clinical predictors and mechanical factors that contribute to permanent pacemaker implantation. Arrhythmia Electrophysiol Rev. 2015;4:81–5.CrossRefGoogle Scholar
  7. 7.
    Auffret V, Puri R, Urena M, Chamandi C, Rodriguez-Gabella T, Philippon F, et al. Conduction disturbances after transcatheter aortic valve replacement: current status and future perspectives. Circulation. 2017;136(11):1049–69.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Jilaihawi H, Chakravarty T, Weiss RE, Fontana GP, Forrester J, Makkar RR. Meta-analysis of complications in aortic valve replacement: comparison of Medtronic-Corevalve, Edwards-Sapien and surgical aortic valve replacement in 8,536 patients. Catheter Cardiovasc Interv. 2012;80(1):128–38.PubMedCrossRefGoogle Scholar
  9. 9.
    Siontis GC, Juni P, Pilgrim T, Stortecky S, Bullesfeld L, Meier B, et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol. 2014;64(2):129–40.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Yater WM, Cornell VH. Heart block due to calcareous lesions of the bundle of his: review and report of a case with detailed histopathologic study. Ann Intern Med. 1935;8:777–89.CrossRefGoogle Scholar
  11. 11.
    Piazza N, de Jaegere P, Schultz C, Becker AE, Serruys PW, Anderson RH. Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Interv. 2008;1:74–81.CrossRefGoogle Scholar
  12. 12.
    van der Boon RM, Nuis RJ, Van Mieghem NM, Jordaens L, Rodes-Cabau J, van Domburg RT, et al. New conduction abnormalities after TAVI—frequency and causes. Nat Rev Cardiol. 2012;9(8):454–63.PubMedCrossRefGoogle Scholar
  13. 13.
    Moreno R, Dobarro D, Lopez de Sa E, Prieto M, Morales C, Calvo Orbe L, et al. Cause of complete atrioventricular block after percutaneous aortic valve implantation: insights from a necropsy study. Circulation. 2009;120(5):e29–30.PubMedCrossRefGoogle Scholar
  14. 14.
    Kawashima T, Sato F. Visualizing anatomical evidences on atrioventricular conduction system for TAVI. Int J Cardiol. 2014;174(1):1–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Hamdan A, Guetta V, Klempfner R, Konen E, Raanani E, Glikson M, et al. Inverse relationship between membranous septal length and the risk of atrioventricular block in patients undergoing transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2015;8(9):1218–28.PubMedCrossRefGoogle Scholar
  16. 16.
    Regueiro A, Abdul-Jawad Altisent O, Del Trigo M, Campelo-Parada F, Puri R, Urena M, et al. Impact of new-onset left bundle branch block and periprocedural permanent pacemaker implantation on clinical outcomes in patients undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis. Circ Cardiovasc Interv. 2016;9(5):e003635.PubMedCrossRefGoogle Scholar
  17. 17.
    Husser O, Pellegrini C, Kessler T, Burgdorf C, Thaller H, Mayr NP, et al. Predictors of permanent pacemaker implantations and new-onset conduction abnormalities with the SAPIEN 3 balloon-expandable transcatheter heart valve. JACC Cardiovasc Interv. 2016;9(3):244–54.PubMedCrossRefGoogle Scholar
  18. 18.
    Rampat R, Khawaja MZ, Byrne J, MacCarthy P, Blackman DJ, Krishnamurthy A, et al. Transcatheter aortic valve replacement using the repositionable LOTUS valve: United Kingdom experience. JACC Cardiovasc Interv. 2016;9(4):367–72.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Zaman S, McCormick L, Gooley R, Rashid H, Ramkumar S, Jackson D, et al. Incidence and predictors of permanent pacemaker implantation following treatment with the repositionable Lotus transcatheter aortic valve. Catheter Cardiovasc Interv. 2017;90(1):147–54.PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Manoharan G, Linke A, Moellmann H, Redwood S, Frerker C, Kovac J, et al. Multicentre clinical study evaluating a novel resheathable annular functioning self-expanding transcatheter aortic valve system: safety and performance results at 30 days with the portico system. EuroIntervention. 2016;12(6):768–74.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Erkapic D, De Rosa S, Kelava A, Lehmann R, Fichtlscherer S, Hohnloser SH. Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature. J Cardiovasc Electrophysiol. 2012;23(4):391–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Nuis RJ, Van Mieghem NM, Schultz CJ, Tzikas A, Van der Boon RM, Maugenest AM, Cheng J, Piazza N, van Domburg RT, Serruys PW, de Jaegere PP. Timing and potential mechanisms of new conduction abnormalities during the implantation of the Medtronic CoreValve system in patients with aortic stenosis. Eur Heart J. 2011;32:2067–74.PubMedCrossRefGoogle Scholar
  23. 23.
    Nazif TM, Williams MR, Hahn RT, Kapadia S, Babaliaros V, Rodes-Cabau J, et al. Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. Eur Heart J. 2014;35(24):1599–607.PubMedCrossRefGoogle Scholar
  24. 24.
    Aktug O, Dohmen G, Brehmer K, Koos R, Altiok E, Deserno V, et al. Incidence and predictors of left bundle branch block after transcatheter aortic valve implantation. Int J Cardiol. 2012;160(1):26–30.PubMedCrossRefGoogle Scholar
  25. 25.
    Franzoni I, Latib A, Maisano F, Costopoulos C, Testa L, Figini F, et al. Comparison of incidence and predictors of left bundle branch block after transcatheter aortic valve implantation using the CoreValve versus the Edwards valve. Am J Cardiol. 2013;112(4):554–9.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Schymik G, Tzamalis P, Bramlage P, Heimeshoff M, Würth A, Wondraschek R, Gonska BD, Posival H, Schmitt C, Schröfel H, Luik A. Clinical impact of a new left bundle branch block following TAVI implantation: 1-year results of the TAVIK cohort. Clin Res Cardiol. 2015;104:351–62.PubMedCrossRefGoogle Scholar
  27. 27.
    Tzamtzis S, Viquerat J, Yap J, Mullen MJ, Burriesci G. Numerical analysis of the radial force produced by the Medtronic-CoreValve and Edwards-SAPIEN after transcatheter aortic valve implantation (TAVI). Med Eng Phys. 2013;35(1):125–30.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Hein-Rothweiler R, Jochheim D, Rizas K, Egger A, Theiss H, Bauer A, et al. Aortic annulus to left coronary distance as a predictor for persistent left bundle branch block after TAVI. Catheter Cardiovasc Interv. 2017;89(4):E162–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Nijenhuis VJ, Van Dijk VF, Chaldoupi SM, Balt JC, Ten Berg JM. Severe conduction defects requiring permanent pacemaker implantation in patients with a new-onset left bundle branch block after transcatheter aortic valve implantation. Europace. 2017;19(6):1015–21.PubMedCrossRefGoogle Scholar
  30. 30.
    Zannad F, Huvelle E, Dickstein K, van Veldhuisen DJ, Stellbrink C, Kober L, et al. Left bundle branch block as a risk factor for progression to heart failure. Eur J Heart Fail. 2007;9(1):7–14.PubMedCrossRefGoogle Scholar
  31. 31.
    Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013;34(29):2281–329.PubMedCrossRefGoogle Scholar
  32. 32.
    Fadahunsi OO, Olowoyeye A, Ukaigwe A, Li Z, Vora AN, Vemulapalli S, et al. Incidence, predictors, and outcomes of permanent pacemaker implantation following transcatheter aortic valve replacement: analysis from the US Society of Thoracic Surgeons/American College of Cardiology TVT Registry. JACC Cardiovasc Interv. 2016;9(21):2189–99.PubMedCrossRefGoogle Scholar
  33. 33.
    Kodali S, Thourani VH, White J, Malaisrie SC, Lim S, Greason KL, et al. Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. Eur Heart J. 2016;37(28):2252–62.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Wendler O, Schymik G, Treede H, Baumgartner H, Dumonteil N, Ihlberg L, et al. SOURCE 3 registry: design and 30-day results of the European postapproval registry of the latest generation of the SAPIEN 3 transcatheter heart valve. Circulation. 2017;135(12):1123–32.CrossRefGoogle Scholar
  35. 35.
    Seeger J, Gonska B, Rottbauer W, Wohrle J. Outcome with the repositionable and retrievable Boston Scientific Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve in patients undergoing transfemoral aortic valve replacement. Circ Cardiovasc Interv. 2017;10(6):e004670. Scholar
  36. 36.
    Pilgrim T, Stortecky S, Nietlispach F, Heg D, Tueller D, Toggweiler S, et al. Repositionable versus balloon-expandable devices for transcatheter aortic valve implantation in patients with aortic stenosis. J Am Heart Assoc. 2016;5(11)
  37. 37.
    Kalra SS, Firoozi S, Yeh J, Blackman DJ, Rashid S, Davies S, et al. Initial experience of a second-generation self-expanding transcatheter aortic valve: the UK & Ireland Evolut R Implanters’ Registry. JACC Cardiovasc Interv. 2017;10(3):276–82.CrossRefGoogle Scholar
  38. 38.
    Popma JJ, Reardon MJ, Khabbaz K, Harrison JK, Hughes GC, Kodali S, et al. Early clinical outcomes after transcatheter aortic valve replacement using a novel self-expanding bioprosthesis in patients with severe aortic stenosis who are suboptimal for surgery: results of the Evolut R US study. JACC Cardiovasc Interv. 2017;10(3):268–75.CrossRefGoogle Scholar
  39. 39.
    Noble S, Stortecky S, Heg D, Tueller D, Jeger R, Toggweiler S, et al. Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis. EuroIntervention. 2017;12(18):e2170–6.CrossRefGoogle Scholar
  40. 40.
    Meredith Am IT, Walters DL, Dumonteil N, Worthley SG, Tchetche D, Manoharan G, et al. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study. J Am Coll Cardiol. 2014;64(13):1339–48.PubMedCrossRefGoogle Scholar
  41. 41.
    Del Trigo M, Dahou A, Webb JG, Dvir D, Puri R, Abdul-Jawad Altisent O, et al. Self-expanding portico valve versus balloon-expandable SAPIEN XT valve in patients with small aortic annuli: comparison of hemodynamic performance. Rev Esp Cardiol (Engl Ed). 2016;69(5):501–8.CrossRefGoogle Scholar
  42. 42.
    Perlman GY, Cheung A, Dumont E, Stub D, Dvir D, Del Trigo M, et al. Transcatheter aortic valve replacement with the portico valve: one-year results of the early Canadian experience. EuroIntervention. 2017;12(13):1653–9.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Bagur R, Teefy PJ, Kiaii B, Diamantouros P, Chu MWA. First North American experience with the transfemoral ACURATE-neo(TM) self-expanding transcatheter aortic bioprosthesis. Catheter Cardiovasc Interv. 2017;90(1):130–8.PubMedCrossRefGoogle Scholar
  44. 44.
    Jatene T, Castro-Filho A, Meneguz-Moreno RA, Siqueira DA, Abizaid AAC, Ramos AIO, et al. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis. Catheter Cardiovasc Interv. 2017;90(1):139–46.CrossRefGoogle Scholar
  45. 45.
    Treede H, Mohr FW, Baldus S, Rastan A, Ensminger S, Arnold M, et al. Transapical transcatheter aortic valve implantation using the JenaValve system: acute and 30-day results of the multicentre CE-mark study. Eur J Cardiothorac Surg. 2012;41(6):e131–8.PubMedCrossRefGoogle Scholar
  46. 46.
    Kempfert J, Meyer A, Kim WK, Van Linden A, Arsalan M, Blumenstein J, et al. Comparison of two valve systems for transapical aortic valve implantation: a propensity score-matched analysis. Eur J Cardiothorac Surg. 2016;49(2):486–92.PubMedCrossRefGoogle Scholar
  47. 47.
    Kempfert J, Holzhey D, Hofmann S, Girdauskas E, Treede H, Schrofel H, et al. First registry results from the newly approved ACURATE TA TAVI systemdagger. Eur J Cardiothorac Surg. 2015;48(1):137–41.PubMedCrossRefGoogle Scholar
  48. 48.
    Chamandi C, Regueiro A, Auffret V, Rodriguez-Gabella T, Chiche O, Barria A, et al. Reported versus “real” incidence of new pacemaker implantation post-transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;68(21):2387–9.PubMedCrossRefGoogle Scholar
  49. 49.
    Toggweiler S, Stortecky S, Holy E, Zuk K, Cuculi F, Nietlispach F, et al. The electrocardiogram after transcatheter aortic valve replacement determines the risk for post-procedural high-degree AV block and the need for telemetry monitoring. JACC Cardiovasc Interv. 2016;9(12):1269–76.CrossRefGoogle Scholar
  50. 50.
    Chamandi C, Barbanti M, Munoz-Garcia A, Latib A, Nombela-Franco L, Gutierrez-Ibanez E, et al. Long-term outcomes in patients with new permanent pacemaker implantation following transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018;11(3):301–10.CrossRefGoogle Scholar
  51. 51.
    Urena M, Webb JG, Tamburino C, Muñoz-García AJ, Cheema A, Dager AE, Serra V, Amat-Santos IJ, Barbanti M, Immè S, Briales JH, Benitez LM, Al Lawati H, Cucalon AM, García Del Blanco B, López J, Dumont E, Delarochellière R, Ribeiro HB, Nombela-Franco L, Philippon F, Rodés-Cabau J. Permanent pacemaker implantation after transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function. Circulation. 2014;129:1233–43.CrossRefGoogle Scholar
  52. 52.
    van Gils L, Tchetche D, Lhermusier T, Abawi M, Dumonteil N, Rodriguez Olivares R, et al. Transcatheter heart valve selection and permanent pacemaker implantation in patients with pre-existent right bundle branch block. J Am Heart Assoc. 2017;6(3)
  53. 53.
    Amat-Santos IJ, Rodes-Cabau J, Urena M, DeLarochelliere R, Doyle D, Bagur R, et al. Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. J Am Coll Cardiol. 2012;59(2):178–88.CrossRefGoogle Scholar
  54. 54.
    Durand E, Eltchaninoff H, Canville A, Bouhzam N, Godin M, Tron C, et al. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT prosthesis. Am J Cardiol. 2015;115(8):1116–22.PubMedCrossRefGoogle Scholar
  55. 55.
    Leclercq F, Iemmi A, Lattuca B, Macia JC, Gervasoni R, Roubille F, et al. Feasibility and safety of transcatheter aortic valve implantation performed without intensive care unit admission. Am J Cardiol. 2016;118(1):99–106.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Jorn Brouwer
    • 1
    Email author
  • Vincent J. Nijenhuis
    • 1
  • Uday Sonker
    • 2
  • Jurrien M. ten Berg
    • 1
  1. 1.Department of CardiologySt. Antonius Hospital NieuwegeinNieuwegeinThe Netherlands
  2. 2.Department of Cardiothoracic SurgerySt. Antonius Hospital NieuwegeinNieuwegeinThe Netherlands

Personalised recommendations